🔎 Trials Near Me

Почетна › Меланом › Ilinois › Chicago

Kliničke studije za Меланом u gradu Chicago, IL

15 studija za Меланом traži učesnike na lokacijama u gradu Chicago i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Тражи се учесникФаза 1/2
  • Call for Information (Investigational Site 0024), Chicago
6 Months – 17 Years · Оба пола · Ажурирано 13. 11. 2026. · NCT02332668

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Тражи се учесникФаза 2
  • Northwestern University, Chicago
  • University of Illinois, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT05136196

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Тражи се учесникФаза 1/2
  • University of Illinois Cancer Center, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT04198766

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • Mount Sinai Hospital Medical Center, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • и још 1
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Тражи се учесникОпсервациона студија
  • John H Stroger Jr Hospital of Cook County, Chicago
  • Advocate Illinois Masonic Medical Center, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06418204

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 2
  • University of Illinois Cancer Center, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06172478

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Тражи се учесникФаза 1/2
  • Northwestern University, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT05896839

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Тражи се учесникФаза 3
  • Northwestern University, Chicago
  • Swedish Covenant Hospital, Chicago
Узраст 75 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT07068074

Project: Every Child for Younger Patients With Cancer

Тражи се учесникОпсервациона студија
  • Lurie Children's Hospital-Chicago, Chicago
  • Northwestern University, Chicago
  • University of Illinois, Chicago
  • и још 1
До 25 година · Оба пола · Ажурирано 25. 8. 2026. · NCT02402244

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Тражи се учесникФаза 1/2
  • Lurie Children's Hospital-Chicago, Chicago
12 Months – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT04851119

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Тражи се учесникФаза 1/2
  • University of Chicago Medical Center, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 13. 5. 2026. · NCT03686124

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Тражи се учесникФаза 1/2
  • University of Chicago, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 28. 4. 2026. · NCT06413680

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Тражи се учесникФаза 2/3
  • Northwestern Memorial Hospital, Chicago
  • University of Chicago Medical Center, Chicago
Сви узрасти · Оба пола · Ажурирано 2. 4. 2026. · NCT06581406

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, Chicago
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Тражи се учесник
  • Advocate Illinois Masonic Medical Center, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 27. 11. 2024. · NCT03860883

Studije za Меланом u drugim gradovima

Ostale studije u gradu Chicago

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.